EUVIMEDEUVIMED entdecken
Crossref

Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking

Genhong Qiu, Li Yu, Lei Jia, Yanfei Cai, Yun Chen, Jian Jin, Lei Xu, Jingyu Zhu

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-10918-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Genhong Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, Jiangsu, 214122, China. Hauptthemen laut MEDLINE: Janus Kinase 3, Molecular Docking Simulation, Protein Kinase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Project Sponsored by the Scientific Research Foundation of Changzhou Vocational Institute of Engineering, Postgraduate Research & Practice Innovation Program of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulated research strongly indicates that Janus kinase 3 (JAK3) is intricately involved in the initiation and advancement of a diverse range of human diseases, underscoring JAK3 as a promising target for therapeutic intervention. However, JAK3 shows significant homology with other JAK family isoforms, posing substantial challenges in the development of JAK3 inhibitors. To address these limitations, one strategy is to design selective covalent JAK3 inhibitors. Therefore, this study introduces a virtual screening approach that combines common feature pharmacophore modeling, covalent docking, and consensus scoring to identify novel inhibitors for JAK3. First, common feature pharmacophore models were constructed based on a selection of representative covalent JAK3 inhibitors. The optimal qualitative pharmacophore model proved highly effective in distinguishing active and inactive compounds. Second, 14 crystal structures of the JAK3-covalent inhibitor complex were chosen for the covalent docking studies. Following validation of the screening performance, 5TTU was identified as the most suitable candidate for screening potential JAK3 inhibitors due to its higher predictive accuracy. Finally, a virtual screening protocol based on consensus scoring was conducted, integrating pharmacophore mapping and covalent docking. This approach resulted in the discovery of multiple compounds with notable potential as effective JAK3 inhibitors. We hope that the developed virtual screening strategy will provide valuable guidance in the discovery of novel covalent JAK3 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 3Molecular Docking SimulationProtein Kinase InhibitorsHumansDrug Evaluation, PreclinicalDrug DesignProtein BindingStructure-Activity RelationshipPharmacophore

Stichwörter der Autor:innen

Consensus scoringCovalent JAK3 inhibitorCovalent dockingPharmacophoreVirtual screening

Substanzen

Janus Kinase 3Protein Kinase InhibitorsJAK3 protein, human

Autor:innen und Institutionen

  • School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, Jiangsu, 214122, China.
  • School of Inspection and Testing Certification, Changzhou Vocational Institute of Engineering, Changzhou, 213164, Jiangsu, China.
  • Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, 213001, China.
  • School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, Jiangsu, 214122, China. jingyuzhu@jiangnan.edu.cn.

Förderung

  • Project Sponsored by the Scientific Research Foundation of Changzhou Vocational Institute of Engineering
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • University-Industry Cooperation Research Project in Jiangsu

Zitieren

APA

Qiu, G., Yu, L., Jia, L., Cai, Y., Chen, Y., Jin, J., Xu, L., & Zhu, J. (2025). Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking. Molecular Diversity. https://doi.org/10.1007/s11030-024-10918-5

Vancouver

Qiu G, Yu L, Jia L, Cai Y, Chen Y, Jin J, et al. Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking. Molecular Diversity. 2025. doi:10.1007/s11030-024-10918-5

BibTeX
@article{Qiu2025,
  author = {Qiu, Genhong and Yu, Li and Jia, Lei and Cai, Yanfei and Chen, Yun and Jin, Jian and Xu, Lei and Zhu, Jingyu},
  title = {Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-10918-5}
}
Kostenlos starten →